UChicago 19th Annual International Ultmann Chicago Lymphoma Symposium 2022

Overview

27 videos, size: 3.45 GB

Information:

List of Topics:

Biology of Follicular Lymphoma.ts
Bispecific Antibodies in Lymphomas.ts
CAR T-Cell Constructs in Lymphoma Current and Future Options.ts
CAR T-Cell Therapy and Emerging Bispecifics for the Treatment of Follicular Lymphoma.ts
Cellular Therapy in Lymphoma Where Are We Now.ts
CLL Present and Future.ts
COVID-19 in Patients With Lymphoma Treatment Approaches, Vaccination, and Prophylactic Strategies.ts
Debate Auto-HCT Remains the Preferred Standard of Care for 1L Therapy of MCL.ts
Debate We Should Stop Doing Autotransplants for Patients With MCL in 1st Remission.ts
Follicular Lymphoma Management in the COVID-19 Era.ts
High-Grade B-Cell Lymphomas, Not Otherwise Specified How To Differentiate and What To Do.ts
Hodgkin Lymphoma Updates Relapse After Auto-HCT, Brentuximab Vedotin, and Checkpoint Inhibitors The Next Frontier.ts
How to Sequence Non-CAR T-Cell Therapy for Relapsed DLBCL.ts
Impact of the Immune Landscape on Hodgkin Lymphoma Prognosis and Treatment.ts
Mantle Cell Lymphoma Case-Based Approach to Management.ts
Post-Acute Outcomes After HL An Epidemiologic Perspective.ts
Prevention of CNS Progression in DLBCL.ts
Primary CNS Lymphoma Focus on Consolidation.ts
Prognostication and Treatment of Burkitt Lymphoma in the Modern Era.ts
Recent Advances in the Frontline Treatment of DLBCL Is There a New Standard of Care.ts
Sequencing of Therapies in R R MCL.ts
T-Cell Lymphomas Impact of Classification on Treatment.ts
Targeted Agents in Follicular Lymphoma Small Molecules.ts
Toxicities Associated With Chronic Therapies for Lymphoma Case Studies.ts
Treatment of 1st Relapsed Classical Hodgkin Lymphoma.ts
Treatment of Relapsed CNS Lymphomas.ts
Venous Thromboembolism in Lymphoma Risk Stratification, Prophylaxis, and Treatment.ts